Lipid mediators in organ transplantation: does cyclosporine accelerate coronary atherosclerosis?
Hess
M L
ML
Hastillo
A
A
Thompson
J A
JA
Sansonetti
D J
DJ
Szentpetery
S
S
Barnhart
G
G
Lower
R R
RR
D000293:Adolescent; D000328:Adult; D000961:Antilymphocyte Serum / Q000008:administration & dosage; D001379:Azathioprine / Q000008:administration & dosage; D002648:Child; D003327:Coronary Disease / Q000209:etiology*; D003524:Cyclosporins / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D005500:Follow-Up Studies; D016027:Heart Transplantation; D006801:Humans; D006937:Hypercholesterolemia / Q000139:chemically induced / Q000150:complications*; D008297:Male; D008875:Middle Aged; D011241:Prednisone / Q000008:administration & dosage; D012306:Risk; D013601:T-Lymphocytes / Q000276:immunology; D013997:Time Factors
D000961:Antilymphocyte Serum; D003524:Cyclosporins; D001379:Azathioprine; D011241:Prednisone